Kenneth E. Carlson

2.5k citations

40 papers · 1.5k indexed · h-index 20

Co-authors: Douglas McDonald David R. Manning David Izrael Lawrence F. Brass S. Hunt Jay M. Janz Yong Ren Marílyn J. Woolkalís
Topics: Receptor Mechanisms and Signaling (9 papers)Opioid Use Disorder Treatment (6 papers)Biochemical Analysis and Sensing Techniques (5 papers)
Cited by: Anesthesiology and Pain Medicine Endocrine and Autonomic Systems Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Journal of Biological Chemistry
Partner nations: United States Canada United Kingdom

In The Last Decade

Kenneth E. Carlson

39 papers receiving 1.4k citations

Peers

Countries citing papers authored by Kenneth E. Carlson

Since Specialization

Citations

This map shows the geographic impact of Kenneth E. Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth E. Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth E. Carlson more than expected).

Fields of papers citing papers by Kenneth E. Carlson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth E. Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth E. Carlson. The network helps show where Kenneth E. Carlson may publish in the future.

Co-authorship network of co-authors of Kenneth E. Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth E. Carlson. A scholar is included among the top collaborators of Kenneth E. Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth E. Carlson. Kenneth E. Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics 2025 ·Frontiers in Molecular Biosciences ·(unknown),(unknown),(unknown),(unknown),Sylvie G. Bernier,Kenneth E. Carlson,Donald E. Ingber	0
2	PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19 2022 ·Communications Biology ·James Logue,Arup Chakraborty,Robert M. Johnson,Girija Goyal,Melissa Rodas,Louis J. Taylor,Lauren Baracco,Marisa E. McGrath,Robert Haupt,(unknown),(unknown),(unknown),Viktor Horváth,Kenneth E. Carlson,Stuart Weston,Donald E. Ingber,Melvin Depamphilis,Matthew B. Frieman	13
3	Associations between spouse and service member prescriptions for high-risk and long-term opioids: A dyadic study 2021 ·Addictive Behaviors Reports ·(unknown),Sharmini Radakrishnan,Nida H. Corry,(unknown),Kenneth E. Carlson,(unknown),Valerie A. Stander	2
4	An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension 2019 ·Diabetologia ·John P. Hanrahan,Jelena Seferović,James Wakefield,Phebe Wilson,(unknown),Joon Jung,Kenneth E. Carlson,Daniel P. Zimmer,Andrew L. Frelinger,Alan D. Michelson,Linda Morrow,Michael Hall,Mark G. Currie,G. Todd Milne,Albert T. Profy	27
5	Estimating the Prevalence of Opioid Diversion by “Doctor Shoppers” in the United States 2013 ·PLoS ONE ·Douglas McDonald,Kenneth E. Carlson	79
6	Assessment of beta‐cell function in young patients with type 2 diabetes: arginine‐stimulated insulin secretion may reflect beta‐cell reserve 2013 ·Journal of Internal Medicine ·Mikaela Sjöstrand,Kenneth E. Carlson,Hans J. Arnqvist,Soffia Guðbjörnsdóttir,Mona Landin‐Olsson,Stina Lindmark,L. Nyström,Maria Svensson,Jan W. Eriksson,Jan Bolinder	12
7	Geographic Variation in Opioid Prescribing in the U.S. 2012 ·Journal of Pain ·Douglas McDonald,Kenneth E. Carlson,David Izrael	239
8	Characterization of a novel and selective CB1 antagonist as a radioligand for receptor occupancy studies 2011 ·Bioorganic & Medicinal Chemistry Letters ·Yifan Yang,Keith J. Miller,Yeheng Zhu,Hong Yang,Yuan Tian,Natesan Murugesan,Zhengxiang Gu,(unknown),(unknown),Kenneth W. Rohrbach,(unknown),Kamelia Behnia,Mary Ann Pelleymounter,Kenneth E. Carlson,William R. Ewing	2
9	G protein–coupled receptor modulation with pepducins: moving closer to the clinic 2011 ·Annals of the New York Academy of Sciences ·(unknown),Kenneth E. Carlson,Michel Bouvier,Craig Gérard,Lei Xu,Lidija Covic,Anika Agarwal,Oliver P. Ernst,Jay M. Janz,Thue W. Schwartz,Thomas J. Gardella,Graeme Milligan,Athan Kuliopulos,Thomas P. Sakmar,S. Hunt	36
10	Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells 2010 ·Proceedings of the National Academy of Sciences ·Boris Tchernychev,Yong Ren,Perminder S. Sachdev,Jay M. Janz,(unknown),(unknown),(unknown),Richard Looby,Qing Deng,Thomas J. McMurry,Manija A. Kazmi,Thomas P. Sakmar,S. Hunt,Kenneth E. Carlson	87
11	Cannabinoid CB1 receptor ligand binding and function examined through mutagenesis studies of F200 and S383 2010 ·European Journal of Pharmacology ·Doree Sitkoff,Ning Lee,Bruce A. Ellsworth,Qi Huang,(unknown),(unknown),Yanting Huang,Chong‐Qing Sun,Annapurna Pendri,Mary F. Malley,Raymond P. Scaringe,Jack Z. Gougoutas,Patricia H. Reggio,William R. Ewing,Mary Ann Pelleymounter,Kenneth E. Carlson	8
12	The melanocortin MC₁ receptor agonist BMS‐470539 inhibits leucocyte trafficking in the inflamed vasculature 2010 ·British Journal of Pharmacology ·Giovanna Leoni,(unknown),Kenneth E. Carlson,(unknown),Sussan Nourshargh,Mauro Perretti	34
13	Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series 2007 ·Bioorganic & Medicinal Chemistry Letters ·Bruce A. Ellsworth,Ying Wang,Yeheng Zhu,Annapurna Pendri,Samuel W. Gerritz,Chong‐Qing Sun,Kenneth E. Carlson,(unknown),(unknown),Yifan Yang,Qi Huang,Neil T. Burford,Mary Jane Cullen,(unknown),Kamelia Behnia,Mary Ann Pelleymounter,William N. Washburn,William R. Ewing	23
14	Sodium salicylate inhibits TNF-α-induced NF-κB activation, cell migration, invasion and ICAM-1 expression in human melanoma cells 2006 ·Melanoma Research ·(unknown),John W. Haycock,(unknown),Kenneth E. Carlson,Yifan Yang,(unknown),Paul Lorigan,Sheila MacNeil	22
15	Immobilized α-melanocyte stimulating hormone 10–13 (GKPV) inhibits tumor necrosis factor-α stimulated NF-κB activity 2005 ·Peptides ·(unknown),Arthur J.G. Moir,Kenneth E. Carlson,Yifan Yang,Sheila MacNeil,John W. Haycock	11
16	Discovery of 4′-[(Imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/Angiotensin II receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·John E. Tellew,(unknown),Sophie Beyer,Kenneth E. Carlson,Lyndon A. M. Cornelius,(unknown),Zhengxiang Gu,(unknown),Mark C. Kowala,Hossain Monshizadegan,Natesan Murugesan,Carol S. Ryan,Maria Valentine,Yifan Yang,John E. Macor	13
17	Design of Novel Chimeric Melanotropin−Deltorphin Analogues. Discovery of the First Potent Human Melanocortin 1 Receptor Antagonist 2003 ·Journal of Medicinal Chemistry ·G. Han,J. Mark Quillan,Kenneth E. Carlson,Wolfgang Sadée,Victor J. Hruby	13
18	Acute hemodynamic effects of terazosin in hypertensive and normotensive patients 1991 ·American Heart Journal ·Joel A. Strom,Benjamin Zola,William H. Frishman,Atul Laddu,John Wexler,Kenneth E. Carlson,(unknown)	2
19	Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Nicole Mahy,Marílyn J. Woolkalís,Kyriaki Thermos,Kenneth E. Carlson,Donald C. Manning,Terry Reisine	33
20	Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton. 1986 ·Molecular Pharmacology ·Kenneth E. Carlson,Marílyn J. Woolkalís,(unknown),David R. Manning	54

About Kenneth E. Carlson

Kenneth E. Carlson is a scholar working on Biological Psychiatry, Endocrine and Autonomic Systems and Cellular and Molecular Neuroscience, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Opioid Use Disorder Treatment (6 papers) and Biochemical Analysis and Sensing Techniques (5 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (135 citations), Endocrine and Autonomic Systems (100 citations) and Cellular and Molecular Neuroscience (263 citations). Kenneth E. Carlson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Douglas McDonald, David R. Manning, David Izrael, Lawrence F. Brass, S. Hunt, Jay M. Janz, Yong Ren, Marílyn J. Woolkalís, Thomas J. McMurry and S H Zigmond. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact